Fosamax was acquired in 2021 by Organon, which agreed to indemnify Merck against liability from the lawsuits. (Pierson, 9/20) Reuters: J&J Unit Files For Bankruptcy To Advance $10 Billion Talc ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

At the heart of the event was Organon’s commitment to empowering women through access to safe and effective family planning ...

Organon shares have stabilized in recent times, with gradual debt reduction and structural growth allowing for a valuation re ...

Congress in Spain were a major feature of research news last week, including those from Pfizer on it ponsegromab in cancer ...

A U.S. appeals court on Friday revived more than 500 lawsuits alleging that Merck & Co failed to warn that its osteoporosis ...

Dubai - McCann Health ME is proud to announce that it has been recognized as one of the Best Workplaces for Women 2024, marking the second consecutive year of receiving this esteemed accolade.

Basel, Switzerland Friday, September 20, 2024, 13:00 Hrs [IST] ...

Organon (OGN) concluded the recent trading session at $20.18, signifying a +1.05% move from its prior day's close.

Organon acquires ROIV's Dermavant for $1.2B, expanding their dermatology portfolio and potentially increasing sales. Click ...

Organon & Co (OGN) stock saw a decline, ending the day at $19.97 which represents a decrease of $-0.58 or -2.82% from the prior close of $20.55. The stock opened at $20.51 and touched a low of $19.42 ...

The Roivant company is dedicated to developing and commercializing innovative therapeutics in immune-dermatology.